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Abstract 
Increasing consumption of Antibiotics like β-lactam antibiotics including Penicillins and 
Cephalosporins has resulted in the creation of refractory E. coli levels to these antibiotics. The aim 
of this study is investigating the presence of resistant gene to β-lactam antibiotics and third-
generation Cephalosporins among separated E. coli levels from urine sample of the referring 
children under 6 infected with urinary tract infection to Tehran central pathobiology laboratory. 130 
s E.coli sample were collected from urine sample of the children. Sensitivity of the collected levels 
to β-lactam antibiotics including Ampicillin, Amoxicillin and third generation Cephalosporins was 
measured. Also, PCR was implemented for finding BLA-SHV gen. Among 130 samples under 
study, 45 samples comported BLA-SHV gen. 100 samples (77%) were resistant toward Amoxicillin 
and Ampicillin antibiotics and 30 samples (23%) were sensitive to these antibiotics. In this study, 
resistant percentage rate to non-ß-lactam antibiotics like Amikacin, Gentamicin, Cotrimoxazole, and 
Ciprofloxacin was respectively 0%, 14%, 66% and 23%. This study has shown the presence of 
BLA-SHV gen with an abundance of 35% in E. coli bacteria and it also confirms the importance of 
awareness of growing increase of Antibiotic resistance and reduction and change in antibiotics’ 
consumption strategy.  
Keywords: E.coli, Antibiotic resistance, broad ß-lactamases, BLA-SHV gene 
 
Introduction 
Urinary tract infection is one of the most common infectious diseases all over the world. 
Urinary tract infection can only infect lower urinary tract that in this case, it is called bladder 
infection. It also might involve upper urinary tract that in this case, it is called Pyelonephritis which 
is the result of microorganisms’ presence in urinary tract. 
Symptoms related to lower urinary tract include excretion of urine along with burning and 
pain or urination frequency, whereas, symptoms related to Pyelonephritis include fever and flank 
pain along with relevant symptoms to lower urinary tract infection. Such symptoms might be 
ambiguous or unknown in elderly or very young members. Urinary tract infections usually occur 
more in women than in men. This is because; half of women, during their life are at least infected by 
an infection. Re-emergence of illness is a common problem. Risk maker factors include: females 
‘body anatomy, sexual intercourse and family history. Pyelonephritis, in case of occurrence, usually 
appears after bladder infection. But it might also result from transmitted infection via blood 
(Nicolle, 2008). 
Lower urinary tract infection is also called bladder infection. Its most common symptoms 
include burning on urination and the need to frequent urination (or urge to urination) and 
considerable pain. Such symptoms might be sever or medium, and in healthy women, they last on 
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average 6 days. People who are infected by upper urinary tract infection or Pyelonephritis might 
show flank pain, fever or nausea and vomiting in spite of common symptoms of lower urinary tract 
infection. Rarely is the urine bloody or with dirt. Diagnosis of this illness in young and healthy 
women is only possible through the symptoms. Diagnosis of illness might be problematic in the 
individuals with ambiguous symptoms; because, bacterias might exist, but no infection is observed. 
In complicated cases or when treatment fails, urine culture might be important (Woodford and 
George, 2011). In patients with recurrent infections, we can use low dose of Antibiotics as the 
preventive measurement. In non-complicated cases, urinary tract infections can easily be treated by 
consuming Antibiotic in a short-term, though resistance against many used Antibiotics for treating 
this illness is increasing (Colgan and Williams, 2011). In complicated cases, it may be necessary 
that treatment courses be extended more or intravenous antibiotics injection might be needed, and in 
the case that the symptoms didn’t improve during two or three days, more diagnostic tests are 
needed. In women, urinary tract infections are the most common form of bacterial infections, and 
any year, 10% is added to the rate of urinary tract infections (Lane and Takhar, 2011). 
Early diagnosis and rapid antimicrobial treatment are necessary in order for minimizing renal 
scarring and progressive kidney damages. In patients with suspected UTI, antibiotic treatment 
usually starts experimentally before culture reply is prepared. Unfortunately, antibiotic resistance is 
an increasing critical problem in many countries like Iran (Aminzadeh, 2008; Al-Tawfiq and Anani, 
2009). In clear cases, we can proceed toward diagnosis and treatment only based on the symptoms, 
and there is no need for more confirmation through experimental tests. In complex or suspected 
cases, diagnosis confirmation might be useful through urine analysis and search for the presence of 
nitrite in urine, white blood cells (leukocytes) or esterase leukocyte (esterase leukocyte test 
measures the rate of esterase enzyme which is released through white blood cells). One of the other 
experiments, namely microscopic examination of urine, searches for the presence of red blood cells, 
white blood cells or bacteria. Urine culture is positive in the case that the number of bacterial 
colonies is greater or equal to 103 colony-forming units (CFU) in common organisms per ml in 
urinary tract. Antibiotic susceptibility is also testable by this culture, and in this regard, it is useful in 
selecting antibiotic therapy. However, antibiotic treatment might again result in improvement in 
women culture result of whom is negative. Because, the symptoms might be ambiguous, and 
diagnosis in elderly members without trustworthy experiments related to urinary tract infections 
might be problematic (Rosen et al., 2017). 
The most important foundation of treatment is using antibiotics. Sometimes during the first 
few days, in spite of antibiotic, phenazopyridine is prescribed in order to help the irritation relief and 
compulsion removal due to bladder infection. However, due to safety problems associated with its 
use and especially the increase of the danger of being affected by methemoglobinemia 
(methemoglobinemia rate higher than normal level of blood), its continuous usage is not 
recommended (Perrotta et al., 2008; Cubeddu et al., 2009). 
The most common factor of urinary tract infection creation is 75-90 % E. coli bacteria, and 
following that Klebsiella spp. ،Enterobacter spp ،Proteus spp and Pseudomonas spp are among 
gram-negative bacterias of urinary tract infection creation. Among gram-positive bacterias creating 
urinary tract infections, we can refer to Group B ß-Streptococcus ،Enterococcus sp. ،MRSA 
،negative Staphylococcus Coagulase. Also, Bacterias such as Chlamydia and Mycoplasma can be 
the cause of urinary tract infection that in spite of other microorganisms, infection with this 
bacterium is considered a part of STD. Infection with the funguses is also observed in some cases 
(Mabeck et al., 1999). 
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In this regard, the aim of the present research is evaluating the frequency of ß-lactamase 
gene (BLA-SHV) in separated E. Colis in referring children under six infected with urinary tract 
infection to Tehran central pathobiology laboratory (2014) that we studied. 
 
Materials and Methods 
Standard method of detector disks of ESBLs 
In this method, a ß-lactamase inhibitor is used which is usually Clavulanic acid along with 
one of Oxy Mino cephalosporins antibiotics such as Cefotaxime or Ceftazidime or Ceftriaxone, in a 
way that Clavulanic acid results in ESBLs inhibition, so that it reduces the resistance of bacteria 
toward Cephalosporins, and we can observe growth inhibition region around the disk which includes 
Clavulanic acid. But, around the disk which lacks Clavulanic acid, growth inhibition region is not 
observed or it is observed less than semi-sensitive or resistant state. In this case, existence or non-
existence of ESBLs in the intended bacteria is discovered. It is necessary to mention that this 
method is known to Combination disk method test (CDT) due to using two disks in this method.  
Needed materials and equipment for recognizing ESBLs 
- Mueller-Hinton agar medium 
- Used disks in order for recognizing ESBLs which have been provided by MAST 
company, including: 
Cefotaxime disk along with Cefotaxime disk+ Clavulanic acid 
- Ceftriaxone disk along with Ceftriaxone disk+ Clavulanic acid 
- Sterile physiology serum 
- 0.5 standard McFarland tubes 
- Bacterial suspension 
- Sterile swaps and pence 
- Graph rule 
Like Antibiotic susceptibility determination methods, medium is prepared and microbial 
suspension is inoculated to the medium through diffusion from disk method. Using delicate sterile 
pence, disks are placed at a distance of thirty mm from each other on Mueller-Hinton agar medium. 
Then, plates are inverted and are placed in incubator at 35 to 37 ° C for 18 to 24 hours. Then, using 
scaled ruler in indirect light and with naked eye, diameter of growth inhibition zones is measured 
and the results are evaluated.  
The increase of zone diameter to 5 millimeter A≥5mm for any of antibiotics in combination 
with Clavulanic acid versus their region is lonely considered as a positive result for ESBL 
production. 
Long-term storage and preservation method of bacterias 
Phosphate buffered saline (PBS) solution is used for maintaining the intended bacteria. 
Bacterial samples are cultured in plate densely for a full day and transferred to micro tubes 
containing PBS in a way that they were taken from grown pure colonies on blood agar medium by 
means of sterile loop, and a microbial suspension was provided in PBS solution according to 
standard solution of Makfarland. Micro tubes containing inoculated bacterial suspension in PBS 
solution can be conserved in freezer for a long time. 
Another method of cultivation was new 24 hours samples on blood agar medium and closure 
of plates’ door or parafilm and maintenance in 2-8 c in refrigerator. 
In for making sure about sample reservation, all above methods were used. 
DNA extraction from separated bacterias for PCR 
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Separated E.coli bacterias are cultured in LB liquid medium and when the number of 
bacterias reached to (1×109) of bacterial cell, they are divided to two sections and any of them are 
centrifuged for 3 minutes in dosage (10000 rpm) 9.300 ×g. zincoid solution is carefully vacated. 
Add the value of 400 μ L of R renewed solubilization buffer to microbial cell mass and 
homogenize it by pipetting. Transfer the homogenized sample to L extraction tube and vertex it a 
bit. 
Incubate the sample in 65c for 10 minutes (alternate shaking increases slip process). 
Place Extraction L tube in thermo maker and incubate it in 95c for 5 to 10 minutes (alternate 
shaking increases slip output). 
Add binding buffer B6 ۴٠٠ Lμ to the sample and vertex it a bit. 
Load the sample in RTA spin filter set and place it in room temperature for 1 minute. Then 
centrifuge it in standard centrifuge (12000 rpm) in 4oo.13 × g. Shed the liquid and turn over RTA 
spin filter in RTA receiver tube. 
Add the Wash buffer I 500 μl and centrifuge it in (10000 rpm) and dosage 9.300 × g for 1 
minute. Shed the liquid and RTA receiver. Place RTA spin filter in a new RTA receiver tube. Add 
the wash buffer II 600 μl and centrifuge it for one minute in dosage (10000 rpm) 9.300 × g. Shed the 
liquid and return RTA spin filter to RTA spin filter and finally centrifuge it for 3 minutes in 
maximum speed in order for the ethanol to be quietly detoxified. 
RTP Bacteria DNA kit contents: 
30 ml Extraction Tube  
30 ml Resuspension Buffer R 
30 ml Binding Buffer B6 
30 ml Elution Buffer D 
Wash Buffer I 30ml (final volume ml 60) 
Wash Buffer II 18ml (final volume ml 60) 
RTA spin filter set 50 
RTA Reciever Tube 50 
1.5 ml Reciever Tubes 50 
In order for extracting blaSHV gen, RTP Bacteria DNA Mini commercial kit made in 
Germany was used the procedures of which are as the following: 
The first stage: 
Add 30 ml of 96-100% ethanol to wash Buffer I bottle and blend it a bit and always close the 
bottles’ door firmly. 
Add 42 ml of 96-100% ethanol to wash Buffer II bottle and blend it a bit and always close 
the bottle’s door tightly. 
Selecting (Forward) and (Reverse) primers in order for PCR of blaSHV gen 
A) In order for searching for finding blaSHV gen in DNA of separated E. coli bacterias and 
based on the information of nucleotide sequence of this gen in papers 17 and then adjustment of this 
data with nucleotide sequence information of this gen in NCBI genbank site, forward and reverse 
primers were selected with the following sequences: 
Forward: 5′-TCATCGAAAAACACCTTG-3′ 
Reverse: 5′-TCCCGCAGATAAATCACC-3′ 
Sharma (2013) in a conducted study in 2013 regarding the spread of blaSHV gen in 
Klebsiella spp and and E. coli, designed the following primers: 
 
F. P: 5`-GTCAGCGAAAAACACCTTGCC-3`  
R. P: 5`- GTCTTATCGGCGATAAACCAG – 3 
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Kariuki et al in the year 2012 in a conducted study on ß-lactamase gene in E.coli designed 
the following primers: 
 
F: 5' – TTCGCCTGTGTATTATCTCCCTG-3' 
R: 5' –TTAGCGTTGCCAGTGYTCG-3' 
In the year 2013, Krishnamurthy et al in a conducted study  
regarding genotypic and phenotypic methods for recognizing generating Klebsiella 
pneumonia of ESBLs, designed the following primers: 
F: 5'- GGGTAATTCTTATTTGTCGC- 3' 
R: 5'- TTAGCGTTGCCAGTGCTC -3' 
Regarding selecting the primer, we should consider some points. For example, the intended 
primer should have 18-25 nucleotides and G=C sequences should exist more at both ends. Tm of the 
used primers shouldn’t differ from each other more than 5 c. Some parts of the gene can be used that 
don’t change. We also should consider the number of nucleotides and lack of complementary 
sequence in designed primers and lack of palindromic sequence. 
Procurement of PCR reaction 
PCR reaction was conducted in final volume of 50 microliter. PCR materials were supplied 
from Cinnagen Company. 
The following materials were respectively added to  
eppendorf tubes specified to PCR: 
PCR water: 18 microliter 
PCR buffer: 2.5 microliter 
dNTP: 1 microliter (equal proportions of dATP,dCTP,dGTP,dTTP was used). 
Forward primer: 0.5 microliter 
Reverse primer: 0.5 microliter 
Then the materials were vertexed a stage and after that 2 microliter of genomic DNA and 
finally 0.5 microliter of Taq DNA Polymerase enzyme was added to them and they immediately 
were transferred to thermo cycler system (eppendorf-model Company). 
PCR reaction was implemented in 35 cycles according to table 1. 
 
Table 1: execution stages of PCR reaction 
Time(second) Temperature (c) PCR reaction stages 
300 95 The first stage  
Denaturation 
 30 95 The next stages 
45 60 Annealing 
30 72 Extention 
600 72 Final Extention 
 
Electrophoresis 
In order for constructing electrophoresis gel, initially, 2 grams of Agarose is blended with 
100 milliliter TBE (%2). The obtained mixture is heated in microwave for several times so that it 
boils but not overflows until a lucid solution is obtained. After complete coolness, gel was poured in 
special format of electrophoresis gel in the liquid state and the intended specific comb was placed in 
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gel and gel was allowed to chill and be solidified. Then, TRAY format was placed in electrophoresis 
tank containing electrophoresis buffer and comb was expelled from that quietly. 
5 microliter of any PCR product was blended with 1 microliter of Erythrogel and they were 
poured in any sinks of Agarose gel. 3 microliter of DNA Ladder (300-1000 bp) was poured in the 
first sink as the marker. Electrophoresis conditions were adjusted on 130 volt for half an hour.  
After necessary time elapse, gel was placed in Ethidium bromide for 15 minutes and after 
that bleaching in distilled water was accomplished. Gel was observed and photographed following 
proximity to ultraviolet in trans-illuminator system. Extracted DNA from Klebsiella pneumoniae 
ATCC 700603 standard stem was used as positive control of SHV gen and extracted DNA from E. 
coli ATCC 25922 was used for negative control. 
 
Results  
The results of separation and recognition of bacterias causing urinary tract infection 
In this study, 130 E. coli strains were under microbiologic evaluation during 3 months from 
October to December of 2014 from 3500 urine samples related to referring under 6 children to 
central pathobiology laboratory.  
230 samples were recognized as positive regarding bacterial infection. 85 % of the infection 
agent was E. coli bacteria and the remained 15% included other gram-negative bacterias such as 
Klebsiella. Proteus sp. Enterobacter sp.sp, Pseudomonas aeroginosa and gram-positive bacterias 
such as Coag. Positive, Enterococcus sp., Group A Streptococci, Group B Streptococci 
Staphylococci and candidiasis infection. Regarding gender, 104 cases 80% were girl and 26 cases 
20% were son. Following cultivating the samples on blood agar medium and EMB and maintenance 
in 37c for 24 hours, purple and often with metallic luster colonies through gram staining and 
biochemical differential tests and Antibiogram tests and samples PCR were confirmed. In anti-bio 
gram studies, 77% of E. coli isolates were resistant to ampicillin and amoxicillin antibiotics. BLA-
SHV ß-lactamase resistance gene was searched among E. coli isolates through PCR method and this 
gen was specified in 35% of E. coli strains. 
 
 
Figure 1: shows E. coli 24 hours medium in EMB agar medium. 
 
 
Figure 2: shows microscopic view of E. coli which is in form of gram-negative bacillus 
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Figure 3: shows differential test of IMViC related to E. coli 
 
Sensitivity evaluation results of E. coli strains to ß-lactam group antibiotics through disk-
inserting method 
Sensitivity of bacterial strains toward ampicillin antibiotics, amikacin, amoxicillin, 
carbenicillin, cephalexin, cephalothin, cefotaxime, cefixime, ceftriaxone, ceftizoxime, ciprofloxacin, 
ofloxacin, cotrimoxazole, gentamicin, nitrofurantoin and nalidixic acid was measured through disk-
inserting method. Figure 4 shows sensitivity evaluation through diffusion from resistant one strain 
disk. 
 
Figure 4: shows sensitivity evaluation to the studied antibiotics through diffusion from 
resistant one strain disk. 
 
Diagram 1 and 2 show the percentage of sensitive, semi-sensitive, and resistant strains to 
ciprofloxacin and ampicillin antibiotics through disk-inserting method in this study. 
 
 
 
Diagram 1: frequency ratio of the number of sensitive, semi-sensitive and resistant E. coli 
strains to ampicillin antibiotic through disk-inserting 
77%
23%
0%
Ampicillin
Resistant
Sensitive
Intermediate
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Diagram 2: frequency ratio of the number of sensitive, semi-sensitive and resistant E. coli 
strains to Ciprofloxacin antibiotic through disk-inserting method 
 
From the summation of 130 studied samples, 100 samples namely 77% were resistant to 
ampicillin antibiotic and 30 samples namely 23% were sensitive to ampicillin antibiotic and in 
opposite, 30 samples namely 23% were resistant to  ciprofloxacin antibiotic and 94 samples namely 
72% were sensitive to  ciprofloxacin antibiotic and 6 samples namely 5% were semi-sensitive to  
ciprofloxacin antibiotic. 
PCR results of BLA-SHV gen in E. coli strains 
After separation and microscopic and biochemical recognition of E. coli strains and 
implementing antibiotic sensitivity determination experiments on them, PCR experiments were 
implemented on strains using related primers to BLA-SHV gen and PCR product was  
electrophoresed. PCR products of the strains with BLA-SHV gen showed a band with molecular 
weight of 210bp (7.77 kDa) in agarose gel (figure 5). 
 
 
Figure 5: electrophoresis of PCR product of BLA-SHV gen in E. coli strains, 
DNA Ladder sink 1, negative control sink 2 (E. coli ATCC 25922), positive control sink 3 
(ATCC 700603 Klebsiella pneumonia), 4 to 8 sinks of E. coli strains with BLA-SHV gen 
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Diagram 3: frequency percentage of sensitivity and resistance to ß-lactam group antibiotics in 
separated E. coli strains in under 6 children infected with urinary tract infection 
 
 
 
Diagram 4: frequency percentage of sensitivity and resistance to the antibiotics of 
cephalosporins, nitrofurantoin, cotrimoxazole group in separated strains of E. coli in under 6 
children infected with urinary tract infection 
 
 
Diagram 5: frequency percentage of sensitivity and resistance to the antibiotics of amino 
glycosides, quinolones and fluoroquinolones group in the strains of separated E. coli in under 
6 children infected with urinary tract infection 
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Table 2: the results of frequency checking of resistance percentage and sensitivity and semi-
sensitivity of E.coli strains to the antibiotics with ß-lactam and also presence and lack of BLA- 
SHV gen in PCR method 
 
Antibiotic 
name 
 
Disk-inserting method Bacteria with BLA-SHV gen 
Bacteria without  
BLA-SHV gen 
Growth 
deterrent 
halation mm 
(Sensitive, 
resistant, 
semi-
sensitive) 
Bacteria 
number 
Bacteria 
percent
age 
 
No. 
 
 
Percentage 
 
No. 
 
 
Percentage 
 
 
Ampicillin 
 
 
Sensitive       
≥ 17 30 23% 0 0% 30 23% 
Resistant       
≤ 13 100 77% 46 35% 54 42% 
Semi-
sensitive    
14-16 
0 0% 0 0% 0 0% 
 
 
Amoxicillin 
 
Sensitive ≥ 18 30 23% 0 0% 30 23% 
Resistant      
≤ 13 100 77% 46 35% 54 42% 
Semi-
sensitive  14-
17 
0 0% 0 0% 0 0% 
 
 
Carbenicilli
n 
 
 
Sensitive ≥ 23 76 59% 0 0% 76 59% 
Resistant   ≤ 
19 52 40% 46 35% 6 5% 
Semi-
sensitive  20-
22 
2 1% 0 0% 2 1% 
 
Cefalexin 
 
 
Sensitive ≥ 18 72 55% 0 0% 72 55% 
Resistant      
≤ 14 54 42% 46 35% 8 7% 
Semi-
sensitive     
15-17 
4 3% 0 0% 4 3% 
 
 
Cephalotin 
 
Sensitive      
≥ 18 74 55% 0 0% 72 55% 
Resistant      
≤ 14 50 42% 46 36% 8 6% 
Semi-
sensitive     
15-17 
6 3% 0 0% 4 3% 
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Table 3: the results of frequency evaluation of resistance percentage and sensitivity and semi-
sensitivity of E.coli strains to the antibiotics with ß-lactam and co-trimoxazole and also 
presence and lack of BLA-SHV gen in PCR method 
 
Antibiotic 
name 
 
Disk- inserting method Bacteria with BLA-SHV gen 
Bacteria without 
BLA-SHV gene 
Growth 
deterrent 
halation mm 
(Sensitive/resist
ant/semi-
sensitive)( 
Bacteria 
number 
Bacteria 
percent 
 
Number 
 
 
Percentag
e 
 
Number 
 
 
 
Percent
age 
 
Cefixime 
 
Sensitive        ≥ 
19 82 63% 0 0% 82 63% 
Resistant        
≤ 15 46 36% 46 36% 0 0% 
Semi-sensitive    
16-18 2 1% 0 0% 2 1% 
Ceftizoxime 
 
sensitive     
    ≥ 20 100 77% 16 12% 84 65% 
Resistant        
≤ 14 26 20% 26 20% 0 0% 
Semi-sensitive 
15-19 4 3% 4 3% 0 0% 
Ceftriaxone 
 
 
Sensitive          
≥ 21 42 57% 0 0% 74 57% 
Resistant        
≤ 13 36 38% 42 32% 8 6% 
Semi-sensitive    
14-20 0 5% 4 4% 1 1% 
Cefotaxime 
 
Sensitive          
≥ 23 40 60% 0 0% 78 60% 
Resistant        
≤ 14 32 35% 42 32% 14 3% 
Semi-sensitive     
15-22 6 5% 4 4% 2 1% 
Co-
trimoxazole 
 
Sensitive          
≥ 16 44 34% 6 5% 38 29% 
Resistant         ≤ 
10 86 66% 40 31% 46 35% 
Semi-sensitive    
11-15 0 0% 0 0% 0 
0% 
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Table 4: the results of frequency evaluation of resistance percentage and sensitivity and semi-
sensitivity of E.coli strains to aminoglycoside antibiotics and quinolines and fluoroquinolones 
and nitrofurantoin, and also the presence and non-presence of BLA-SHV gen in PCR method 
Antibiotic 
name 
Disk-inserting method Bacteria with BLA-SHV gen 
Bacteria without 
BLA-SHV gen 
Growth deterrent 
halation mm 
(Sensitive, 
resistant/semi-
sensitive) 
Bacteria 
number 
Bacteria 
percentage
 
Number
 
 
 
Percentage 
 
Number
 
 
 
Percentage
 
Ciproflox
acin 
Sensitive   ≥ 21 94 72% 30 23% 64 49% 
Resistant  ≤ 15 30 23% 16 12% 14 11% 
Semi-sensitive     
16-20 6 5% 0 0% 6 5% 
Ofloxacin 
Sensitive ≥ 16 92 71% 24 19% 68 52% 
Resistant  ≤ 12 30 23% 22 17% 8 6% 
Semi-sensitive 
13-15 8 6% 0 0% 8 6% 
Gentamici
n 
Sensitive ≥ 15 112 86% 34 26% 78 60% 
Resistant ≤ 12 18 14% 12 9% 6 5% 
Semi-sensitive      
13-14 0 0% 0 0% 0 0% 
Amikacin 
Sensitive ≥ 17 126 97% 46 35% 80 62% 
Resistant ≤ 14 0 0% 0 0% 0 0% 
Semi-sensitive     
15-16 4 3% 0 0% 4 3% 
Nitrofuran
toin 
Sensitive ≥ 17 122 94% 40 31% 82 63% 
Resistant  ≤ 14 6 5% 4 4% 2 1% 
Semi-sensitive    
15-16 2 1% 2 1% 0 0% 
Nalidixic 
acid 
Sensitive ≥ 19 56 64% 10 8% 46 35% 
Resistant ≤ 13 
 72 31% 36 28% 36 28% 
Semi-sensitive14-
18 2 5% 0 0% 2 1% 
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Table 5: presence percentage of BLA-SHV gen and non-presence of BLA-SHV gen in the 
studied sensitive and resistant E. coli strains 
Antibiotic name 
Resistant Sensitive 
Presence of 
BLA-SHV gen 
Non-presence of  
BLA-SHV gen 
Presence of 
BLA-SHV gen 
Non-presence of  
BLA-SHV gen 
Ampicillin 35% 42% 0% 23% 
Amoxicillin 35% 42% 0% 23% 
Carbenicillin 35% 5% 0% 59% 
Cefalexin 35% 7% 0% 55% 
Cephalotin 36% 6% 0% 55% 
Cefixime 36% 0% 0% 63% 
Ceftizoxime 20% 0% 12% 65% 
Ceftriaxone 32% 6% 0% 57% 
Cefotaxime 32% 3% 0% 60% 
Co-trimoxazole 31% 35% 5% 29% 
 
Table 6: presence percentage of BLA-SHV gen and non-presence of BLA-SHV gen in the 
studied resistant and sensitive E. coli strains 
Antibiotic name  
Resistant Sensitive 
Presence of 
BLA-SHV gen 
Non-presence of 
BLA-SHV gen 
Presence of 
BLA-SHV gen 
Non-presence of 
BLA-SHV gen 
Ciprofloxacin 12% 11% 23% 49% 
Ofloxacin 17% 6% 19% 52% 
Gentamicin 9% 5% 26% 60% 
Amikacin 0% 0% 35% 62% 
Nitofurantoin 4% 1% 31% 63% 
Nalidixic acid 28% 28% 8% 35% 
 
From 130 separated E.coli bacterias based on the results of PCR experiments of BLA-SHV 
gen, 46 bacterias with this gen were recognized. The most resistance with 100 isolated bactrerias 
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(77%) was observed about ampicillin and amoxicillin antibiotics that all 35% bacterias with BLA-
SHV gen were in this group. 54 resistant bacterias to ampicillin and amoxicillin antibiotics lacked 
BLA-SHV gen.  
Respectively, resistant strains to carbenicillin with 40% (52 strains), ceftriaxone with 38% 
(36 strains), cefxime with 36% (46 strains) and cefotaxime with 35% (32 strains) and resistant 
strains to cephalexin and cephalotin antibiotics with 42% (54 strains) showed the most antibiotic 
resistance after resistant strains to ampicillin and amoxicillin. Separated Klebsiella strains showed 
the most sensitivity, respectively Amikacin with 97% (126 strains), Gentamicin with 86% (112 
strains), ciprofloxacin with 72% (94 strains) and ofloxacin with 71% (92 strains). 
 
Table 7: Separated E.coli frequency based on age and gender of infected children to urinary 
tract infection 
Microorganism 
Girl Boy The 
number 
of tested 
samples 
0-1 
months 
1 
months- 
3 years 
3-6 
years 
0-1 
months 
1 
months 
-3 years 
3-6 
years 
E. coli 
No. 8 75 21 10 11 5 130 
Percentage 6.1% 57.7% 16.2% 7.7% 8.5% 3.8 % 100% 
 
Table 8: frequency of resistant E.coli strains to antibiotics with ß-lactam based on age and 
gender of children 
ß-lactam antibiotics  
Girl Boy The 
number of 
all resistant 
samples to 
antibiotic 
0-
1months
1 
months 
-3 
years 
3-6 
years
0-1 
months
1months 
-3 years 
3-6 
years 
Ampicillin Number 5 65 15 6 6 3 100 
Percentage  5% 65% 15% 6% 6% 3% 100% 
 
Ceftriaxone 
Number  2 30 9 3 4 2 50 
Percentage  4% 60% 18% 6% 8% 4% 100% 
 
Table 9: frequency of E.coli strains with BLA-SHV gen based on age and gender of infected 
children to urinary tract infection 
 
E. coli 
Strains 
Girl Boy The 
number 
of under 
study 
samples 
0-1 
months 
1 months 
-3 years 
3-6 
years 
0-1 
months 
1 
months-
3 years 
3-6 
years 
The 
presence of 
SHV gen 
No. 3 28 8 2 4 1 46 
Percentage 6.5% 61% 17% 4.5% 9% 2% 35% 
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 Statistical analysis of the data 
Finally, the obtained results were evaluated using version 21 SPSS statistical program in 
order for determining P value indicator. 
 
Table 10: comparing P Value with the presence of BLA-SHV gen in resistant strains and non-
presence of BLA-SHV gen in the studied sensitive strains 
P Value  َ◌Antibiotic 
0.000445 Penicillins  
ßlactams 
 0.000000 Cephalosporins 
0.008 Fluoroquinolones 
0.34 Quinolones 
0.005 Aminoglycosides 
0.001 Co-trimoxazole 
0.213 Nitrofurantoin 
 
The results of calculating P value from comparing the presence of BLA-SHV gen in resistant 
strains and non-presence of BLA-SHV gen in sensitive studied strains for ß-lactam group antibiotics 
(penicillins, cephalosporins), quinolones, aminoglycosides and cotrimoxazole antibiotic is <0.05 that 
this problem represents that the presence of BLA-SHV gen in resistant strains and non-presence of 
BLA-SHV gen in the sensitive studied strains is not accidental and the presence of this gen has been 
in relation with the induction of resistance to the above antibiotics.  
More increase of P Value from the optimum limit for nitrofurantoin and nalidixic acid 
antibiotics  in this paper can result from the association of several gens in resistance affair that in 
this paper, only  BLA-SHV gen has been studied.  
 
Discussion and conclusion 
In recent years, prevalence of the infections due to resistant organisms to ß-lactam antibiotics 
is increasing because of the production of these enzymes. Therefore, recognizing producing strains 
of broad ß-lactamase has a very important role both in the society and hospital. Because, firstly 
these strains exist more than whatever they are recognized. Second, ESBLs are a serious threat for 
nowadays used antibiotics (Krishnamurthy, 1975). Thirdly, the outbreak of infections in health 
centers is increasing due to selective pressure caused by overdose of broad cephalosporins and lack 
of effective controlling systems in consuming these drugs. Therefore, only responding to the 
bacterias with multiple pharmaceutical resistances and rapid and exact recognition of the infections 
caused by these resistant bacterias and antibiotic treatment are suitable. 
Almost 3-5 percent of girls and 1% of boys suffer from urinary tract infection. The average 
age of catching in girls in the first recognition turn is 2 years, namely in the same age they have 
urinary continence. In boys, most urinary tract infections occur in the first year of life and they are 
more common in non- circumcised boys. The amount of prevalence is different depending on age, 
so that in the first year of life, the ratio of urinary tract infection is 2.8/5.4=boy/son and after 1-2 
years, this ratio achieves 1.10. Urinary tract infection is usually caused by colon bacterias. In girls, 
75-90% is E. coli infection and after that Klebsiella sp and Proteus sp are created. Urinary tract 
  
Sohrab Ahrabi, Jalaluddin Derakhshanpour Khamene 
 
Openly accessible at http://www.european-science.com                                                                   366 
 
infection has usually been mentioned as an important factor in creating insufficiency of kidney final 
stage. Risk factors in creating urinary tract infection include: gender (girl), non- circumcised boys, 
urine reflux, urinary obstruction, manipulation of the urinary tract, washing of perineum from back 
to front, constipation, anatomic abnormalities like labia adherence and neurogenic bladder. 
In Iran, different studies have been implemented in this regard that we can refer to the 
following cases. In accomplished studies by Mobin et al. (2010) on clinical samples which took 
place in ICU departments of three training hospital of Shariati, Sina, children’s medical center; from 
among 150 isole of enterobacteriaceae family, 89 isole were the producer of ESBL. The most 
common enterobacteriaceae species producing ESBL included: klebsiella pneumonia 76%, E. coli 
60%, enterobacter kolvase 47%. This study showed that producer enterobacteriaceae bacterias of 
ESBL in Patients in ICU section were prevalent.  
In another conducted study by Reza Torshizi et al. (2008) on separated enterobacteriaceae 
isolates in training hospitals of Shahr-e Kord, the spread of broad ß-lactamase was 28% and 
frequency of CTX-M ß-lactamase gen in all positive phenotype enterobacteriaceaes was reported 
50.5%. 
Nowadays, the problem of resistance to ß-lactam drugs and broad cephalosporins is a serious 
growing problem and due to the limitation of these antimicrobial materials, we need new antibiotics 
for their replacement. The findings of this research show that in the studied society, the amount of 
resistance to third generation cephalosporins and also the spread of generating ESBLs strains are 
rather high. Therefore, in order for controlling the infections caused by such microorganisms, we 
should consider the following points: 
- Reduction and change in consumption strategy of antibiotics 
- Increased activity of control committees of hospital infections 
- Patients’ hygiene observance and control principles of hospital infections 
- Exact and rapid recognition of the infections caused by resistant bacterias and 
suitable antibiotic treatment 
- Awareness of the prevalence of ESBLs producing strains in society and hospitals 
- Increasing awareness of the society from drug resistances and its dangers for the 
people and the role of all society members regarding reducing such resistances. 
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